Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

39.74
-0.3383-0.84%
Volume:125.59K
Turnover:4.95M
Market Cap:248.39M
PE:- -
High:39.84
Open:39.47
Low:39.00
Close:40.08
52wk High:40.86
52wk Low:22.12
Shares:6.25M
Float Shares:6.25M
Volume Ratio:1.40
T/O Rate:2.01%
Dividend:0.28
Dividend Rate:0.71%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna’s Personalized MRNA Shot Could Reshape the Fight Against Skin Cancer — but It May Also Be Overhyped

Dow Jones
·
Aug 21

How Moderna’s Historic Short Squeeze Upended the AI Chip Trade

Dow Jones
·
Aug 21

Moderna : JP Morgan Raises Target Price to $77 from $40

THOMSON REUTERS
·
Aug 21

ETF Daily | MRAL Surges 31%; AGQ Gains 5%; UCO Rises 3%; MRNX Plunges 48%; Crypto-Leveraged Products Dominate

ETF Tracker
·
Aug 21

24H | Ross Stores Jumps Over 8% After Earnings; Strategy Rises Another 2%; Moderna Slips Another 2%

US Overnight
·
Aug 21

Press Release: Sunshine Guojian Releases 2026 Interim Report:

Dow Jones
·
Aug 21

Review & Preview: the Market's Terrible, Horrible, no Good, Very Bad Day

Dow Jones
·
Aug 21

Overnight Market Wrap: US Stocks Slide as Long-Dated Treasury Yields Rebound; Moderna Tumbles 23.5%

Stock News
·
Aug 21

Stocks to Watch Thursday Recap: Strategy, Moderna, Walmart

Dow Jones
·
Aug 21

Incyte President, Global Head of R&D Pablo J. Cagnoni Sells 10,801 Shares for $1.36 Million

Reuters
·
Aug 21

Thursday's Top 20 US Stock Transactions: Micron Rises 3.97% Following $10 Billion Research Lab Announcement

Deep News
·
Aug 21

Moderna Inc. Stock Slips 23.5%, Underperforms Peers

Dow Jones
·
Aug 21

Twist Bioscience President and COO Patrick John Finn Disposes of 78,355 Common Shares Worth $9.28 Million

Reuters
·
Aug 21

Sector Update: Healthcare

MT Newswires Live
·
Aug 21

Moderna is up 350% Since Our Recommendation. Here's What to Do Next.

Dow Jones
·
Aug 21

Revolution Medicines Advances RASolve 308 Lung Cancer Trial, Raising Long-Term Upside Potential for RVMD

TIPRANKS
·
Aug 21

Moderna’s RSV Vaccine Trial Reaches Completion, Setting Up a Key Catalyst for MRNA

TIPRANKS
·
Aug 21

Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial

TIPRANKS
·
Aug 21

Moderna falls -19.9%

TIPRANKS
·
Aug 21

After Day of Exuberance for Moderna's Stock, Investors Pull Back

Dow Jones
·
Aug 20